2021³â ´ëÇѺҾÈÀÇÇÐȸ Ãß°èÇмú´ëȸ (4Â÷ »ê¾÷Çõ¸í ½Ã´ë, ºÒ¾ÈÀå¾Ö Áø´Ü°ú Ä¡·á¸¦ À§ÇØ ³ª¾Æ°¥ ±æ) : 2021-11-12±³À°ÀÏÀÚ : 2021-11-12
±³À°Àå¼Ò : ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë
±³À°ÁÖÁ¦ :
2021³â ´ëÇѺҾÈÀÇÇÐȸ Ãß°èÇмú´ëȸ (4Â÷ »ê¾÷Çõ¸í ½Ã´ë, ºÒ¾ÈÀå¾Ö Áø´Ü°ú Ä¡·á¸¦ À§ÇØ ³ª¾Æ°¥ ±æ)ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺҾÈÀÇÇÐȸ (ÀÌ»çÀåÁ¦)
´ã´çÀÚ : À¯Çö¾Æ
¿¬¶ôó : 031-787-7434
À̸ÞÀÏ :
benzcl500@naver.com ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 13 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ïºñ : [ȸ¿øÀü¹®ÀÇ 3¸¸¿ø], [ºñȸ¿øÀü¹®ÀÇ 4¸¸¿ø], [±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 2¸¸¿ø], [Æò»ýȸ¿ø ¸éÁ¦] / ÇöÀåµî·ÏÀº ¹ÞÁö ¾Ê½À´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 09:30~09:50 The Electrophysiological Change Related to Childhood Trauma in Paitients with MDD ÇãÀμö(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 09:50~10:10 Neural Correlates of Resilience in Healthy Adults ±èÇöÁÖ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 10:10~10:30 Gender Differences in Suicidal Ideation Associated with Long Working Hours among Korean Employees: Kangbuk Samsung Workplace Mental Health Study ÀÌÈñÁØ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 10:30~10:50 Core Clinical Symptoms and Suicidal Ideation in Patients with Obsessive-Compulsive Disorder: A Network Analysis ±è½ÅÅÂ(¿¬¼¼ÀÇ´ë)
Åä·Ð 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 10:50~11:00 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 11:10~12:10 Self-compassion, an antidote for self-criticism ÀÌ°æ¿í(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 12:20~12:45 When could Vortioxetine be a relevant treatment option for patients with MDD living through the pandemic? À±Á¦¿¬(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 12:45~13:10 Dose-response relationship among antidepressant treatment option and for Vortioxetine ¼È£ÁØ(°¡Å縯ÀÇ´ë)
Åä·Ð 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 13:10~13:20 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 13:30~13:50 ºÒ¾È, ¿ì¿ï¿¡¼ÀÇ ¼ö¿ëÀü³äÄ¡·áÀÇ ¿ªÇÒ ¹× °³¿ä ÀÌ°¿í(°¿øÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 13:50~14:10 ¼ö¿ëÀü³äÄ¡·áÀÇ »ý¹°ÇÐÀû, ³ú¿µ»óÇÐÀû ±Ù°Å ±è¹Î°æ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 14:10~14:30 ºÒ¾È, ¿ì¿ïÀÇ ½É¸®»çȸÇÐÀû ¿äÀο¡ ´ëÇÑ ¼ö¿ëÀü³äÄ¡·á Àû¿ë Á¶¼ºÁØ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 14:30~14:50 ÀÓ»óÇöÀå¿¡¼ÀÇ ¼ö¿ëÀü³äÄ¡·á Àû¿ë ÀüºÀÈñ(¸¶À½°ú¸¶À½ Á¤½Å°Ç°ÀÇÇаú)
Åä·Ð 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 14:50~15:00 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 15:10~15:35 Application of the Mindfulness-based Approaches À̺´Ã¶(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 15:35~16:00 Application of Acceptance and Commitment Skills ÀÌ»ó¿ø(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 16:00~16:25 Application of the Inhibitory Learning Model of Exposure ³ë´ë¿µ(ÇѸ²ÀÇ´ë)
Åä·Ð 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ëA 16:25~16:40 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 09:30~09:55 ³í¹®ÀÛ¼ºÀ» À§ÇÑ PubMed È°¿ë ±è³ª¿ø(¿¬¼¼ÀÇÇеµ¼°ü)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 09:55~10:20 ¼º°øÀûÀÎ SCI Åõ°í Àü·« ±èÈÖÃâ(Editage)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 10:20~10:45 ºÒ¾ÈÀå¾Ö ¿¬±¸À±¸® - Àç³ Á¤½Å°Ç°À» Áß½ÉÀ¸·Î ¹éÁ¾¿ì(°æÈñÀÇ´ë)
Åä·Ð 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 10:45~11:00 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 11:10~12:10 Self-compassion, an antidote for self-criticism ÀÌ°æ¿í(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 12:20~12:45 Anxiety & Depression in the COVID °ÁöÀÎ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 12:45~13:10 Pandemia Benefits of Agomelatine treatment strategies ±è¿ø(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 13:10~13:20 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 13:30~13:50 AI¸¦ ÀÌ¿ëÇÑ ºÒ¾È, ¿ì¿ïÀÇ digital phenotyping Á¶Ã¶Çö(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 13:50~14:10 À¯Àü ¹× »ý¹°ÇÐÀû µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÑ AI Áø´Ü ÃֽŠµ¿Çâ ¹ÚõÀÏ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 14:10~14:30 ³úÆÄ ¹× ³ú¿µ»ó µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÑ AI Áø´Ü ÃֽŠµ¿Çâ ±èÁö¼±(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 14:30~14:50 AI¸¦ ÀÌ¿ëÇÑ ºÒ¾È ¹× ¿ì¿ï Àå¾Ö Áø´Ü ±â¼úÀÇ È¿¿ë¼º ¹× Á¦ÇÑÁ¡ ¿ÀÁöÈÆ(°¡Å縯ÀÇ´ë)
Åä·Ð 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 14:50~15:00 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 15:10~15:30 Á¤½Å°ú ¿µ¿ª¿¡¼ µðÁöÅÐ Ä¡·áÁ¦ °³¹ß ÇöȲ ¿ÀÁöÇý(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 15:30~15:50 °¡»óÇö½Ç ±â¹Ý ÀÎÁöÇൿġ·á¿Í µðÁöÅÐ Ä¡·áÁ¦ ¿ÀÁÖ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 15:50~16:10 µðÁöÅÐ Ä¡·áÁ¦´Â ±¹³» ÀÇ·áȯ°æ¿¡ Á¤Âø°¡´ÉÇÒ±î? ½ÅÀç¿ë(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 16:10~16:30 ºÒ¾È, ¿ì¿ï¿¡ ´ëÇÑ µðÁöÅÐ Ä¡·áÁ¦ °³¹ßÀ» À§ÇØ ³ª¾Æ°¥ ±æ ÀüÈ«Áø(¼º±Õ°üÀÇ´ë)
Åä·Ð 11-12 ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï ±×·£µåº¼·ë ·ë C 16:10~16:30 ÁúÀÇÀÀ´ä ()